Fusafungine

CHEMBL2109188 Phase 4 Onaylandı Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
639.8 g/mol
LogP
6.5
Phase
4

An antibiotic with anti-inflammatory properties used to treat infections of the nose and throat. It is applied directly as a spray to the affected area.

Moleküler Ağırlık

639,8000 g/mol

LogP

6,50

TPSA

140,00 Ų

Lipinski RO5

Başarısız

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)[C@H]1C(=O)OC(C(=O)N([C@H](C(=O)OC(C(=O)N([C@H](C(=O)OC(C(=O)N1C)C(C)C)C(C)C)C)C(C)C)C(C)C)C)C(C)C

InChI

InChI=1S/C33H57N3O9/c1-16(2)22-31(40)43-26(20(9)10)29(38)35(14)24(18(5)6)33(42)45-27(21(11)12)30(39)36(15)23(17(3)4)32(41)44-25(19(7)8)28(37)34(22)13/h16-27H,1-15H3/t22-,23-,24-,25?,26?,27?/m0/s1

Molecular Formula

C33H57N3O9

HBD / HBA

- / 9

Döndürülebilir Bağlar

6

Ağır Atomlar

45

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

An antibiotic with anti-inflammatory properties used to treat infections of the nose and throat. It is applied directly as a spray to the affected area.

Yes, Fusafungine is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2109188. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3084092. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.